The Stoneygate Trust and the University of Leicester are providing significant funding to turbocharge a number of key kidney research initiatives by renal experts.

A pilot programme for people living with Chronic Kidney Disease in Leicester, Leicestershire and Rutland (LLR) is helping to revolutionise patient care and could be rolled out elsewhere.

Thousands of people living with rare kidney disease will have access to improved diagnostics, treatments and potentially cures, thanks to the creation of a new research centre, involving experts from the University of Leicester.

Dorset HealthCare has joined forces with University Hospitals Dorset for a pioneering trial of a treatment to help people regain use of their arms after a stroke.

One of the co-chairs of the award-winning Trend Diabetes will lead an educational session at the inaugural Diabetes Nursing Awards.

Artificial intelligence once felt like it had a home only in science fiction stories, but there’s no doubt it’s now becoming an integral part of our world.

AI has an important role to play in the future of healthcare, offering doctors and healthcare professionals the ability to improve patient care and automate labour-intensive tasks.

Fresh insights into a protein that causes damage in kidneys and heart could open up new treatment options for chronic kidney disease, research shows.

Renal hyperfiltration may be an underestimated risk factor for mortality, according to new research from the University of Eastern Finland.

A new study has shown the importance of Covid-19 vaccines in patients who have had a kidney transplant.

Young adults who experience kidney function decline tend to have accelerated progression to more severe chronic kidney disease and higher risk of cardiovascular disease and death in middle age.

AstraZeneca, a leader in cardiorenal research, presented new data at the American Society of Nephrology (ASN) Kidney Week 2022 in Orlando, Florida, US on the importance of earlier screening and diagnosis of chronic kidney disease (CKD) and the impact of Farxiga on reducing healthcare costs1,2.

A big group of bacteria found in our soil and our water are harmless for most of us, but a new study indicates they are associated with an increased risk of dying in individuals whose kidneys have failed.

Studies have suggested psoriasis is an independent risk factor for heart attack in the general population, but investigators have made the surprising finding that in people who also have end-stage renal disease, which shares many risk factors with heart disease, it is not.

All health and care staff should receive training in artificial intelligence (AI) with additional specialist training for those who use AI tools in clinical practice, according to new research published this week.